Exogenous PDGF-D Is a Potent Mesangial Cell Mitogen and Causes a Severe Mesangial Proliferative Glomerulopathy

Journal of the American Society of Nephrology

Volumn 15, Issue 2, 2004, Pages 286-298

  Hudkins, Kelly L ^a   Gilbertson, Debra G ^b   Carling, Matthew ^a   Taneda, Sekiko ^a   Hughes, Steven D ^b   Holdren, Matthew S ^b   Palmer, Thomas E ^b   Topouzis, Stavros ^b   Haran, Aaron C ^b   Feldhaus, Andrew L ^b   Alpers, Charles E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b ZYMOGENETICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR D; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; FEMALE; GENE OVEREXPRESSION; KIDNEY INJURY; MESANGIUM CELL; MITOGENICITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 0942265458     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000108522.79652.63     Document Type: Article

References (50)

1. Johnson R, Iida H, Yoshimura A, Floege J, Bowen-Pope DF: Platelet-derived growth factor: A potentially important cytokine in glomerular disease. Kidney Int 41: 590-594, 1992
2. Johnson RJ, Floege J, Couser WG, Alpers CE: Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 4: 119-128, 1993
3. Alpers CE, Johnson RJ: Growth factors and the glomerulus: Relationships between development and injury. Adv Nephrol Necker Hosp 24: 33-52, 1995
4. Floege J, Topley N, Resch K: Regulation of mesangial cell proliferation. Am J Kidney Dis 17: 673-676, 1991
5. Floege J, Topley N, Hoppe J, Barrett TB, Resch K: Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: Modulation and/or suppression by inflammatory cytokines. Clin Exp Immunol 86: 334-341, 1991
6. Gilbertson DG, Duff ME, West JW, Kelly JD, Sheppard PO, Hofstrand PD, Gao Z, Shoemaker K, Bukowski TR, Moore M, Feldhaus AL, Humes JM, Palmer TE, Hart CE: Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem 276: 27406-27414, 2001
7. LaRochelle WJ, Jeffers M, McDonald WF, Chillakuru RA, Giese NA, Lokker NA, Sullivan C, Boldog FL, Yang M, Vernet C, Burgess CE, Fernandes E, Deegler LL, Rittman B, Shimkets J, Shimkets RA, Rothberg JM, Lichenstein HS: PDGF-D, a new protease-activated growth factor. Nat Cell Biol 3: 517-521, 2001
8. Li X, Ponten A, Aase K, Karlsson L, Abramsson A, Uutela M, Backstrom G, Hellstrom M, Bostrom H, Li H, Soriano P, Betsholtz C, Heldin CH, Alitalo K, Ostman A, Eriksson U: PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2: 302-309, 2000
9. Heldin CH, Westermark B: Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316, 1999
10. Hart CE, Forstrom JW, Kelly JD, Seifert RA, Smith RA, Ross R, Murray MJ, Bowen-Pope DF: Two classes of PDGF receptor recognize different isoforms of PDGF. Science 240: 1529-1531, 1988
11. Seifert RA, Hart CE, Phillips PE, Forstrom JW, Ross R, Murray MJ, Bowen-Pope DF: Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem 264: 8771-8778, 1989
12. Claesson-Welsh L, Eriksson A, Moren A, Severinsson L, Ek B, Ostman A, Betsholtz C, Heldin CH: cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol Cell Biol 8: 3476-3486, 1988
13. Floege J, Ostendorf T, Wolf G: Growth factors and cytokines. In: Immunologic Renal Diseases, edited by Neilson EG, Couser WG, 2nd Ed., Baltimore, Lippincott Williams & Wilkins, 2001
14. Johnson RJ, Floege J, Couser WG, Alpers CE: Role of platelet-derived growth factor in glomerular disease [Editorial]. J Am Soc Nephrol 4: 119-128, 1993 [published erratum appears in J Am Soc Nephrol 4: 1237, 1993]
15. Johnson RJ, Floege J, Couser WG, Alpers CE: Role of platelet-derived growth factor in glomerular disease [Editorial]. J Am Soc Nephrol 4: 119-128, 1993 [published erratum appears in J Am Soc Nephrol 4: 1237, 1993]
16. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF, Johnson RJ: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92: 2952-2962, 1993
17. Floege J, Ostendorf T, Janssen U, Burg M, Radeke HH, Vargeese C, Gill SC, Green LS, Janjic N: Novel approach to specific growth factor inhibition in vivo: Antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol 154: 169-179, 1999
18. Iida H, Seifert R, Alpers CE, Gronwald RG, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF, et al.: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A 88: 6560-6564, 1991
19. Ostendorf T, Kunter U, Grone HJ, Bahlmann F, Kawachi H, Shimizu F, Koch KM, Janjic N, Floege J: Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 12: 909-918, 2001
20. Eitner F, Ostendorf T, Van Roeyen C, Kitahara M, Li X, Aase K, Grone HJ, Eriksson U, Floege J: Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney. J Am Soc Nephrol 13: 910-917, 2002
21. Eitner F, Ostendorf T, Kretzler M, Cohen CD, Eriksson U, Grone HJ, Floege J: PDGF-C Expression in the developing and normal adult human kidney and in glomerular diseases. J Am Soc Nephrol 14: 1145-1153, 2003
22. Changsirikulchai S, Hudkins KL, Goodpaster TA, Volpone J, Topouzis S, Gilbertson DG, Alpers CE: Platelet-derived growth factor-D expression in developing and mature human kidneys. Kidney Int 62: 2043-2054, 2002
23. Hudkins KL, Giachelli CM, Cui Y, Couser WG, Johnson RJ, Alpers CE: Osteopontin expression in fetal and mature human kidney. J Am Soc Nephrol 10: 444-457, 1999
24. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41: 1134-1142, 1992
25. Alpers CE, Seifert RA, Hudkins KL, Johnson RJ, Bowen-Pope DF: Developmental patterns of PDGF B-chain, PDGF-receptor, and alpha-actin expression in human glomerulogenesis. Kidney Int 42: 390-399, 1992
26. Segerer S, Eitner F, Cui Y, Hudkins KL, Alpers CE: Cellular injury associated with renal thrombotic microangiopathy in human immunodeficiency virus-infected macaques. J Am Soc Nephrol 13: 370-378, 2002
27. Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, Couser WG, Alpers CE: Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol 14: 968-980, 2003
28. Alpers CE, Hudkins KL, Pritzl P, Johnson RJ: Mechanisms of clearance of immune complexes from peritubular capillaries in the rat. Am J Pathol 139: 855-867, 1991
29. Eitner F, Cui Y, Hudkins KL, Schmidt A, Birkebak T, Agy MB, Hu SL, Morton WR, Anderson DM, Alpers CE: Thrombotic microangiopathy in the HIV-2-infected macaque. Am J Pathol 155: 649-661, 1999
30. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE: The activated mesangial cell: a glomerular "myofibroblast"? J Am Soc Nephrol 2[Suppl]: S190-S197, 1992
31. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87: 847-858, 1991
32. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92: 2597-2601, 1993
33. Lotze MT, Kost TA: Viruses as gene delivery vectors: Application to gene function, target validation, and assay development. Cancer Gene Ther 9: 692-699, 2002
34. McDonald GA: Targeted adenoviral gene transfer to the kidney. Kidney Int Suppl 61[Suppl 1]: 42-46, 2002
35. Imai E: Gene therapy approach in renal disease in the 21st century. Nephrol Dial Transplant 16[Suppl 5]: 26-34, 2001
36. Seifert RA, Coats SA, Oganesian A, Wright MB, Dishmon M, Booth CJ, Johnson RJ, Alpers CE, Bowen-Pope DF: PTPRQ is a novel phosphatidylinositol phosphatase that can be expressed as a cytoplasmic protein or as a subcellularly localized receptor-like protein. Exp Cell Res 287: 374-386, 2003
37. Rosenberg I, Cherayil BJ, Isselbacher KJ, Pillai S: Mac-2-binding glycoproteins. Putative ligands for a cytosolic beta-galactoside lectin. J Biol Chem 266: 18731-18736, 1991
38. Segerer S, Hudkins KL, Taneda S, Wen M, Cui Y, Segerer M, Farr AG, Alpers CE: Oral interferon-alpha treatment of mice with cryoglobulinemic glomerulonephritis. Am J Kidney Dis 39: 876-888, 2002
39. Taneda S, Segerer S, Hudkins KL, Cui Y, Wen M, Segerer M, Wener MH, Khairallah CG, Farr AG, Alpers CE: Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol 159: 2355-2369, 2001
40. Vanzulli S, Gazzaniga S, Braidot MF, Vecchi A, Mantovani A, Wainstok de Calmanovici R: Detection of endothelial cells by MEC 13.3 monoclonal antibody in mice mammary tumors. Biocell 21: 39-46, 1997
41. Vecchi A, Garlanda C, Lampugnani MG, Resnati M, Matteucci C, Stoppacciaro A, Schnurch H, Risau W, Ruco L, Mantovani A, et al.: Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur J Cell Biol 63: 247-254, 1994
42. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G: A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 103: 2787-2796, 1986
43. Kubbutat MH, Key G, Duchrow M, Schluter C, Flad HD, Gerdes J: Epitope analysis of antibodies recognising the cell proliferation associated nuclear antigen previously defined by the antibody Ki-67 (Ki-67 protein). J Clin Pathol 47: 524-528, 1994
44. LaRochelle WJ, Robbins KC, Aaronson SA: Immunochemical localization of the epitope for a monoclonal antibody that neutralizes human platelet-derived growth factor mitogenic activity. Mol Cell Biol 9: 3538-3542, 1989
45. Hu Y, Schett G, Zou Y, Dietrich H, Xu Q: Abundance of platelet-derived growth factors (PDGFs), PDGF receptors and activation of mitogen-activated protein kinases in brain decline with age. Brain Res Mol Brain Res 53: 252-259, 1998
46. Hu Y, Zou Y, Dietrich H, Wick G, Xu Q: Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. Circulation 100: 861-868, 1999
47. Matsumoto K, Hiraiwa N, Yoshiki A, Ohnishi M, Kusakabe M: PDGF receptor-alpha deficiency in glomerular mesangial cells of tenascin-C knockout mice. Biochem Biophys Res Commun 290: 1220-1227, 2002
48. Hirsch S, Gordon S: Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4. Immunogenetics 18: 229-239, 1983
49. Alpers CE, Hudkins KL, Ferguson M, Johnson RJ, Rutledge JC: Platelet-derived growth factor A-chain expression in developing and mature human kidneys and in Wilms' tumor. Kidney Int 48: 146-154, 1995
50. Nakagawa H, Sasahara M, Haneda M, Koya D, Hazama F, Kikkawa R: Immunohistochemical characterization of glomerular PDGF B-chain and PDGF beta-receptor expression in diabetic rats. Diabetes Res Clin Pract 48: 87-98, 2000